We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-14.06%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.24B
AUM Growth
-$98.1M
(-7.4%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
11.27%
Top 10 Holdings %
Top 10 Hldgs %
39.9%
Holding
2,819
New
365
Increased
978
Reduced
847
Closed
217
Avg Time Held Equity + Options
2.1
years
Top 10 Avg Time Held Equity + Options
1.3
years
Top 20 Avg Time Held Equity + Options
1.5
years
Avg Time Held Equity only
2.1
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVB Financial
CVBF
|
+$78.5M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$48.7M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$16.1M |
| 4 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$10.8M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$8.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$13.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$7.79M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.79M |
| 4 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$6.62M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$6.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.43% |
| 2 | Technology | 12.95% |
| 3 | Financials | 11.18% |
| 4 | Healthcare | 5.67% |
| 5 | Consumer Discretionary | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2376
Octave Specialty Group
OSG
$207M
| $0 | ﹤0.01% |
+61
| New | +$1.17K |
2020 Q1
0 quarters
|
|
2377
AMC Entertainment Holdings
AMC
$2.7B
| – | – |
-31
| Closed | -$2K | – |
|
2378
Amplify Energy
AMPY
$180M
| – | – |
-128
| Closed | -$1K | – |
|
2379
Alpha Metallurgical Resources
AMR
$2.15B
| $0 | ﹤0.01% |
3
| – | – |
2019 Q1
4 quarters
|
|
2380
AnaptysBio
ANAB
$1.46B
| $0 | ﹤0.01% |
52
-23
| -31% | -$349 |
2019 Q4
1 quarter
|
|
2381
ArcBest
ARCB
$2.97B
| $0 | ﹤0.01% |
+52
| New | +$1.2K |
2020 Q1
0 quarters
|
|
2382
Ares Management
ARES
$25.9B
| $0 | ﹤0.01% |
+4
| New | +$140 |
2020 Q1
0 quarters
|
|
2383
Arrow Financial
AROW
$682M
| $0 | ﹤0.01% |
34
-1
| -3% | -$29 |
2017 Q3
10 quarters
|
|
2384
Arrowhead Research
ARWR
$8.26B
| $0 | ﹤0.01% |
+24
| New | +$968 |
2020 Q1
0 quarters
|
|
2385
Atara Biotherapeutics
ATRA
$96.9M
| – | – |
-2
| Closed | -$1K | – |
|
2386
Astronics
ATRO
$2.65B
| $0 | ﹤0.01% |
+73
| New | +$1.31K |
2020 Q1
0 quarters
|
|
2387
Avalo Therapeutics
AVTX
$644M
| – | – |
0
| – | – |
2020 Q1
0 quarters
|
|
2388
Dauch Corp
DCH
$1.21B
| $0 | ﹤0.01% |
+21
| New | +$156 |
2020 Q1
0 quarters
|
|
2389
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.6B
| $0 | ﹤0.01% |
24
| – | – |
2018 Q4
5 quarters
|
|
2390
JPMorgan BetaBuilders Canada ETF
BBCA
$11.4B
| – | – |
-16
| Closed | -$1K | – |
|
|
BBU
2391
DELISTED
Brookfield Business Partners
BBU
| $0 | ﹤0.01% |
26
| – | – |
2016 Q4
13 quarters
|
|
2392
Brunswick
BC
$4.25B
| $0 | ﹤0.01% |
9
-109
| -92% | -$5.78K |
2019 Q2
3 quarters
|
|
2393
Boise Cascade
BCC
$2.63B
| – | – |
-427
| Closed | -$16K | – |
|
2394
Benchmark Electronics
BHE
$2.63B
| $0 | ﹤0.01% |
50
-115
| -70% | -$3.25K |
2018 Q4
5 quarters
|
|
2395
Beacon Financial Corp
BBT
$2.3B
| – | – |
-240
| Closed | -$8K | – |
|
2396
Boot Barn
BOOT
$3.65B
| $0 | ﹤0.01% |
+27
| New | +$861 |
2020 Q1
0 quarters
|
|
2397
DELISTED
Berry Corp
BRY
| $0 | ﹤0.01% |
22
-72
| -77% | -$442 |
2019 Q4
1 quarter
|
|
2398
John Hancock Financial Opportunities Fund
BTO
$714M
| – | – |
-1,125
| Closed | -$41K | – |
|
2399
Peabody Energy
BTU
$2.93B
| $0 | ﹤0.01% |
22
-71
| -76% | -$455 |
2019 Q4
1 quarter
|
|
2400
Boyd Gaming
BYD
$5.16B
| $0 | ﹤0.01% |
5
-195
| -98% | -$5K |
2018 Q4
5 quarters
|
|
Similar funds
Parallel Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, Parallel Advisors held 2,819 positions worth $1.24B, down 7.4% from $1.33B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Parallel Advisors deployed $139M of net new capital in Q1 2020, opening 365 new positions and adding to 978 existing holdings. Its largest new stake was Adverum Biotechnologies: 5,766 shares worth $563K.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 59% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $13.1M trimmed.
- Parallel Advisors's largest Q1 2020 buy was Adverum Biotechnologies: 5,766 shares worth $563K.
- Parallel Advisors added most to CVB Financial in Q1 2020, an estimated $78.5M increase.
- Parallel Advisors's biggest Q1 2020 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $13.1M.
- Parallel Advisors fully exited State Street SPDR Portfolio Mortgage Backed Bond ETF in Q1 2020, selling an estimated $1.38M.
- Parallel Advisors's ten largest holdings make up 40% of its $1.24B portfolio in Q1 2020.
- Parallel Advisors opened 365 new positions and closed 217 in Q1 2020.
- Parallel Advisors's portfolio value fell 7.4% quarter-over-quarter to $1.24B.
Based on Parallel Advisors's 13F filing for Q1 2020, filed 27 Apr 2020.